SCHEMBL23259137

SCHEMBL23259137

CCc1cn(CC2CC2)c2ccccc2c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.48
PDE4B Q07343 3/20 0.48
PDE4C Q08493 3/20 0.48
PDE4D Q08499 3/20 0.48
CNR2 P34972 6/20 0.47
CNR1 P21554 5/20 0.45
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
ALDH1A1 P00352 1/20 0.42
ICMT O60725 3/20 0.42
HTR2A P28223 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13949764 0.89 CNR1 (0.48) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL24358821 0.81 PDE4A (0.45) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL23259453 0.80 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL9028840 0.77 LMNA (0.64) CNR2CNR1
SCHEMBL30421188 0.77 LMNA (0.64) CNR2CNR1
SCHEMBL31370596 0.77 PADI4 (0.47) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL31230200 0.76 MEN1 (0.49) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL21600842 0.76 MEN1 (0.49) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL24199375 0.76 CNR2 (0.51) CNR2ALDH1A1ICMT
SCHEMBL24199373 0.76 KMT2A (0.51) PDE4BPDE4DCNR2ALDH1A1ICMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225480-B2 Malic enzyme inhibitors SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-01-18 US disclosed
WO-2021074898-A1 MALIC ENZYME INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) 2021-04-22 WO disclosed
US-20210115038-A1 MALIC ENZYME INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2021-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115038-A1 MALIC ENZYME INHIBITORS ME1, ME2, ME3 PDE4A 3247/4885PDE4B 3340/4885PDE4C 3647/4885
US-11225480-B2 Malic enzyme inhibitors ME1, RNASE1, ME2 PDE4A 3868/4885PDE4B 3903/4885PDE4C 4216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.